Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Gastrointestinal Cancer
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
NCT05710406
Colorectal / Colon / Rectal Cancer
Open
Cancer Control
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
NCT03103321
Prostate Cancer
Closed
Jon Tilburt, MD
Pregabalin in Treating Women With Hot Flashes
NCT00702949
Breast Cancer
Closed
Charles Loprinzi, MD
Leukemia
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958
Leukemia & Myelodysplastic Syndromes (MDS), Multiple Myeloma & Plasma Cell Disorders
Open
Clara Bloomfield, MD
Respiratory Cancer
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
NCT00693992
Lung Cancer & Mesothelioma
Closed
Mark A Socinski
Cancer Control
Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
NCT03609021
Breast Cancer
Closed
Marie Wood, MD
Lymphoma
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
NCT01132807
Lymphoma
Closed
David J. Straus, MD
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
NCT00033605
Other Cancer
Closed
James A. Martenson, MD
Leukemia
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
NCT01004965
Leukemia & Myelodysplastic Syndromes (MDS)
Closed
Maria R. Baer, MD
Genitourinary Cancer
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT04164082
Genitourinary Cancers – Kidney / Bladder / Urothelial / Testicular
Open
Michael E Woods

Research in Action

See how Alliance trials are advancing treatment

Alliance News